MQS Management’s NeoGenomics NEO Stock Holding History

MQS Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,155	Closed	-$75.3K	–	408
2026 Q1	$75.3K	Buy	+10,155	New	+$107K	0.05%	360

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

MQS Management's NEO Position: Q2 2026 in Review

MQS Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 10,155 shares — an estimated $75.3K sold.

MQS Management first reported a position in NEO in Q1 2026 and held it in 1 quarter. The position peaked at $75.3K in Q1 2026. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

MQS Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
MQS Management sold 10,155 NeoGenomics shares in Q2 2026, an estimated $75.3K.
MQS Management first reported a position in NeoGenomics in Q1 2026 and held it in 1 quarter.
MQS Management's NeoGenomics position peaked at $75.3K in Q1 2026.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.